Interesting results were obtained in 48 breast samples for master EMT regulators (TWIST1, SNAIL, SLUG) and classical BC receptors (ER, PR, HER2) at the mRNA and protein levels, as well as with disease-free survival (DFS) and overall survival (OS). This evidence concerns the gene ERBB2 and breast cancer.